FFCP PHASE2:Hg19::chr19:856179..856196,+
From FANTOM5_SSTAR
Revision as of 18:41, 27 July 2015 by Autoedit (talk | contribs) (Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=NA |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript |HGNC=NA |TSSclassifier=stron...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p@chr19:856179..856196, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr19:856179..856196, + |
Coexpression cluster: | C209_acute_myelodysplastic_CD34_granulocyte_CD133_liver_spleen |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p@chr19:856179..856196+ |
---|
0
1
2
3
4
5
6
7
8
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
syndrome | 1.84e-34 | 1 |
hematopoietic system disease | 5.48e-18 | 2 |
myeloid leukemia | 1.56e-17 | 31 |
leukemia | 4.53e-14 | 39 |
hematologic cancer | 6.71e-11 | 51 |
immune system cancer | 6.71e-11 | 51 |
cardiovascular system disease | 1.12e-09 | 4 |
Showing 1 to 7 of 7 entries